Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2016
Reporting Period: The filing references financial results for the fourth quarter and full year ended December 31, 2015, which were announced via press release on March 2, 2016.
Key Financial Metrics
The provided text is a procedural filing that references a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for specific numerical metrics.
Material Changes
No specific material changes in financial condition or operations are detailed within the body of this 8-K filing. The document serves to notify the market of the issuance of the Q4 and full-year 2015 results press release and an upcoming investor conference.
Guidance, Outlook, and Events
- Conference Call: The Company scheduled a conference call for March 3, 2016, at 9:00 a.m. Eastern Time to present the financial results.
- Investor Conference: Management is scheduled to present an overview and update at an investor conference in Boston, Massachusetts, on March 7, 2016.
- Forward-Looking Statements: The filing contains standard disclaimers regarding forward-looking statements, noting they are subject to risks and uncertainties detailed in the Company's 2014 Form 10-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 2, 2016) for specific Q4 and full-year 2015 revenue, net loss, and cash position figures.
- Verify the details of the March 3, 2016 conference call for management commentary on the reported results.
- Check the March 7, 2016 investor conference schedule for updates on the Company's pipeline and strategic direction.
- Refer to the 2014 Form 10-K for the comprehensive list of risk factors referenced in this filing.